title: [Results of a multicenter trial of serenoa repens extract (permixon) in patients with chronic abacterial prostatitis].
abstract: Chronic prostatitis (CP) morbidity now makes up 8 to 35% in males aged 20-40 years (N.A. Lopatkin et al., 1998; O.L. Tiktinsky, 1999). In general population CP incidence rate is 5 to 8% (J.C. Nickel, 1999). Phytotherapy is now widely practiced in CP. A multicenter trial conducted by the authors demonstrates high efficacy ofpermixon in the treatment of chronic prostatitis/chronic pelvic pain syndrome. The results of 6-month follow-up are presented.
authors.forename: N A
authors.initials: NA
authors.lastname: Lopatkin
authors.forename: O I
authors.initials: OI
authors.lastname: Apolikhin
authors.forename: A V
authors.initials: AV
authors.lastname: Sivkov
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Aliaev
authors.forename: B K
authors.initials: BK
authors.lastname: Komiakov
authors.forename: V N
authors.initials: VN
authors.lastname: Zhuravlev
authors.forename: V N
authors.initials: VN
authors.lastname: Oshchepkov
authors.forename: A Z
authors.initials: AZ
authors.lastname: Vinarov
authors.forename: I V
authors.initials: IV
authors.lastname: Bazhenov
authors.forename: A A
authors.initials: AA
authors.lastname: Medvedev
authors.forename: L G
authors.initials: LG
authors.lastname: Spivak
authors.forename: A G
authors.initials: AG
authors.lastname: Eliseenko
mesh_terms: D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D011472:Prostatitis / Q000188:drug therapy*; D028024:Serenoa; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D010936:Plant Extracts; C040972:saw palmetto extract